Who makes Medialipide 20% perfusion?

Medialipide 20% perfusion is developed by Hospices Civils de Lyon.

What development phase is Medialipide 20% perfusion in?

Medialipide 20% perfusion is in Phase 2.

Last reviewed 2026-04-19 · How we verify

Medialipide 20% perfusion

Hospices Civils de Lyon · Phase 2 active Small molecule

At a glance

Generic name	Medialipide 20% perfusion
Sponsor	Hospices Civils de Lyon
Modality	Small molecule
Phase	Phase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Development of an Innovative Hemodialysis Method to Improve Dialytic Clearance of Protein-bound Uremic Toxins (PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Medialipide 20% perfusion CI brief — competitive landscape report
Medialipide 20% perfusion updates RSS · CI watch RSS
Hospices Civils de Lyon portfolio CI